|
US6083922A
(en)
*
|
1996-04-02 |
2000-07-04 |
Pathogenesis, Corp. |
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
|
|
US6076520A
(en)
*
|
1997-05-12 |
2000-06-20 |
Cooper; Emily L. |
Device for nasal therapeutic inhalation
|
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
TW465235B
(en)
|
1998-09-17 |
2001-11-21 |
United Video Properties Inc |
Electronic program guide with digital storage
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
JP2002532430A
(ja)
*
|
1998-12-17 |
2002-10-02 |
パソゲネシス コーポレイション |
エアゾール化抗生物質を用いる重篤な慢性気管支炎（気管支拡張症）の処置方法
|
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
|
US8820316B2
(en)
*
|
2000-02-11 |
2014-09-02 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
|
EP1944036A3
(en)
|
2000-02-11 |
2009-01-14 |
Profile Drug Delivery Ltd |
Improvements in and relating to drug delivery
|
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
|
US7971588B2
(en)
*
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
DK1353647T3
(da)
*
|
2000-12-27 |
2011-06-14 |
Gilead Sciences Inc |
Inhalerbar aztreonam til behandling og forebyggelse af bakterielle lungeinfektioner
|
|
US7214364B2
(en)
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
|
ES2261735T3
(es)
|
2001-05-18 |
2006-11-16 |
Chiron Corporation |
Sistema para la administracion de una formulacion de tobramicina.
|
|
EP1598059A1
(en)
|
2001-05-18 |
2005-11-23 |
Chiron Corporation |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
|
SI1273292T1
(en)
*
|
2001-07-02 |
2004-12-31 |
Chiesi Farmaceutici S.P.A. |
Optimised formulation of tobramycin for aerosolization
|
|
US20040022740A1
(en)
*
|
2001-07-10 |
2004-02-05 |
Baker William R. |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
|
EP1458360B1
(en)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Pulmonary delivery of aminoglycosides
|
|
PT3536344T
(pt)
*
|
2002-03-01 |
2020-03-26 |
Chiesi Farm Spa |
Formulação superfina de formoterol
|
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
US8245708B2
(en)
*
|
2002-05-07 |
2012-08-21 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
AU2003238846A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Childrens Hospital And Regional Medical Center |
Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function
|
|
US6966649B2
(en)
*
|
2002-08-12 |
2005-11-22 |
John H Shadduck |
Adaptive optic lens system and method of use
|
|
US20040045546A1
(en)
*
|
2002-09-05 |
2004-03-11 |
Peirce Management, Llc |
Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
CA2541849C
(en)
*
|
2003-10-15 |
2012-07-31 |
Pari Gmbh |
Liquid preparation containing tobramycin
|
|
DK1750667T3
(da)
|
2004-05-17 |
2011-04-26 |
Corus Pharma Inc |
Kombination af fosfomycin/aminoglycosid i aerosolform til behandling af bakterielle luftvejsinfektioner
|
|
WO2006002178A1
(en)
|
2004-06-18 |
2006-01-05 |
Novartis Vaccines And Diagnostics Inc. |
Methods of treatment of endobronchial infections
|
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
|
US7838532B2
(en)
*
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
US8524735B2
(en)
*
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
AU2013206401B2
(en)
*
|
2005-09-29 |
2016-06-23 |
Novartis Ag |
Antibiotic formulations, unit doses, kits, and methods
|
|
CN104586868A
(zh)
*
|
2005-09-29 |
2015-05-06 |
尼克塔治疗公司 |
抗生素制剂、单位剂量、试剂盒以及方法
|
|
PL1962805T3
(pl)
|
2005-12-08 |
2017-01-31 |
Insmed Incorporated |
Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
|
|
WO2007070875A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Aerosol Science Laboratories, Inc. |
Treatment of active infections and related compositions
|
|
JP5600432B2
(ja)
*
|
2006-04-06 |
2014-10-01 |
インスメッド， インコーポレイテッド |
コアセルベート化誘導リポソーム被包法及びその調合物
|
|
US9539303B2
(en)
*
|
2006-04-24 |
2017-01-10 |
Celgene Corporation |
Treatment of Ras-expressing tumors
|
|
WO2007145866A1
(en)
*
|
2006-06-07 |
2007-12-21 |
Wyeth |
Treating cystic fibrosis with antibiotics via a swirler delivery
|
|
WO2007145868A1
(en)
*
|
2006-06-07 |
2007-12-21 |
Wyeth |
Treating cystic fibrosis with antibiotics via an aerosol drug
|
|
US20070286817A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via a swirler delivery
|
|
US20070286818A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via an aerosol drug
|
|
WO2007146730A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Gloucester Pharmaceuticals |
Deacetylase inhibitor therapy
|
|
AU2007296744A1
(en)
|
2006-09-11 |
2008-03-20 |
Curis, Inc. |
Multi-functional small molecules as anti-proliferative agents
|
|
CA2663795A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations and methods for promoting mucus clearance
|
|
JP2008199905A
(ja)
*
|
2007-02-16 |
2008-09-04 |
Snow Brand Milk Prod Co Ltd |
乳酸菌生残性向上剤
|
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9114081B2
(en)
*
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
EP2203155A1
(en)
*
|
2007-09-25 |
2010-07-07 |
Novartis Ag |
Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin
|
|
AU2009246217B2
(en)
|
2008-05-15 |
2013-01-10 |
Novartis Ag |
Pulmonary delivery of a fluoroquinolone
|
|
EP2346509B1
(en)
*
|
2008-10-07 |
2020-05-13 |
Horizon Orphan LLC |
Inhalation of levofloxacin for reducing lung inflammation
|
|
US8815838B2
(en)
|
2008-10-07 |
2014-08-26 |
David C. Griffith |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
|
KR20130130875A
(ko)
|
2009-02-27 |
2013-12-02 |
이난타 파마슈티칼스, 인코포레이티드 |
Ｃ형 간염 바이러스 억제제
|
|
US20120018526A1
(en)
*
|
2009-03-20 |
2012-01-26 |
Livia Tiba |
Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution
|
|
SI2445502T1
(sl)
|
2009-06-25 |
2017-10-30 |
Alkermes Pharma Ireland Limited |
Heterociklične spojine za zdravljenje neuroloških in psiholoških motenj
|
|
NZ598484A
(en)
|
2009-09-04 |
2014-02-28 |
Mpex Pharmaceuticals Inc |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
|
RU2555772C2
(ru)
|
2009-12-14 |
2015-07-10 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Микрочастицы с антибиотиком для ингаляции
|
|
ES2647361T3
(es)
|
2010-01-07 |
2017-12-21 |
Alkermes Pharma Ireland Limited |
Profármacos de sales de amonio cuaternario
|
|
EP2388008A1
(en)
|
2010-05-14 |
2011-11-23 |
Combino Pharm, S.L. |
Stable, preservative-free, aqueous formulation for the administration by aerosolization comprising tobramycin
|
|
WO2011163594A2
(en)
|
2010-06-24 |
2011-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
EP2593110B1
(en)
|
2010-07-12 |
2021-01-06 |
Xellia Pharmaceuticals ApS |
Treatment of lung infections by administration of tobramycin by aerolisation
|
|
ES2661574T3
(es)
|
2010-12-23 |
2018-04-02 |
Alkermes Pharma Ireland Limited |
Profármacos de carga de múltiples PAF
|
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
|
SI2694075T1
(sl)
|
2011-04-01 |
2016-07-29 |
Curis, Inc. |
Fosfoinozitid 3-kinazni inhibitor z delom, ki veže cink
|
|
BR112014000275A2
(pt)
|
2011-07-12 |
2017-04-18 |
Cardeas Pharma Inc |
formulações aperfeiçoadas de combinações de aminoglicosídeo e fosfomicina e métodos e sistemas para o tratamento de pneumonia associada à ventilação mecânica (pavm) e traqueobronquite associada à ventilação mecânica (vat)
|
|
US8826904B2
(en)
|
2011-07-12 |
2014-09-09 |
Cardeas Pharma Corporation |
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
|
|
PT2567691E
(pt)
|
2011-09-12 |
2015-04-09 |
Pari Pharma Gmbh |
Composições aquosas que compreendem arbecacina
|
|
HUE044957T2
(hu)
|
2011-12-15 |
2019-11-28 |
Alkermes Pharma Ireland Ltd |
Samidorphan (ALKS 33) opioid agonistákkal alkotott kombinációja
|
|
AU2012351747B2
(en)
|
2011-12-15 |
2016-05-12 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
GB201208080D0
(en)
|
2012-05-09 |
2012-06-20 |
Norton Healthcare Ltd |
Tobramycin formulation
|
|
NZ700983A
(en)
|
2012-05-21 |
2016-10-28 |
Insmed Inc |
Systems for treating pulmonary infections
|
|
CN102949379B
(zh)
*
|
2012-11-14 |
2014-11-05 |
中山大学 |
硫酸奈替米星吸入粉雾剂及其制备方法
|
|
RU2018135921A
(ru)
|
2012-11-29 |
2019-02-05 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
|
US20140371238A1
(en)
|
2013-03-13 |
2014-12-18 |
Flatley Discovery Lab |
Compounds and methods for the treatment of cystic fibrosis
|
|
EP3125936B1
(en)
|
2014-03-31 |
2019-05-08 |
Debiopharm International SA |
Fgfr fusions
|
|
KR102657132B1
(ko)
|
2014-05-15 |
2024-04-12 |
인스메드 인코포레이티드 |
폐의 비-결핵성 마이코박테리아 감염을 치료하기 위한 방법
|
|
EP4112071A1
(en)
|
2014-08-26 |
2023-01-04 |
HSF Pharmaceuticals |
Novel immunization agents and methods of use
|
|
AU2015328307B2
(en)
|
2014-10-06 |
2019-11-21 |
Apm Therapeutics 1, Inc. |
Triazolopyridine compounds and methods for the treatment of cystic fibrosis
|
|
WO2016089981A1
(en)
*
|
2014-12-04 |
2016-06-09 |
Carefusion 2200, Inc. |
Breath-actuated nebulizer for medicine inhalation
|
|
CN105616345B
(zh)
*
|
2016-03-01 |
2018-08-21 |
上海方予健康医药科技有限公司 |
一种妥布霉素吸入组合物及其制备方法和用途
|
|
KR102398439B1
(ko)
|
2016-03-07 |
2022-05-16 |
이난타 파마슈티칼스, 인코포레이티드 |
B형 간염 항바이러스제
|
|
US11597708B2
(en)
|
2016-09-16 |
2023-03-07 |
Hsf Pharmaceuticals Sa |
Inhibitors of heat shock factors and uses thereof
|
|
EP3688184A1
(en)
*
|
2017-09-29 |
2020-08-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of developing pulmonary colonization/infection bypseudomonas aeruginosa
|
|
WO2019170871A1
(en)
|
2018-03-08 |
2019-09-12 |
Hsf Pharmaceuticals |
Localized activation of virus replication boosts herpesvirus-vectored vaccines
|
|
US11571386B2
(en)
|
2018-03-30 |
2023-02-07 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
BR112020022633A2
(pt)
|
2018-05-10 |
2021-05-04 |
Cis Pharma Ag |
copolímero biocompatível contendo moléculas de agente ativo múltiplas
|
|
US11234986B2
(en)
|
2018-09-11 |
2022-02-01 |
Curis, Inc. |
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
UY38383A
(es)
|
2018-09-21 |
2020-04-30 |
Enanta Pharm Inc |
Heterociclos funcionalizados como agentes antivirales
|
|
EP3653716A1
(en)
|
2018-11-19 |
2020-05-20 |
HSF Pharmaceuticals |
Replication-competent controlled alpha-herpesvirus virus vectors and uses therefore
|
|
GB2565941A
(en)
*
|
2018-11-27 |
2019-02-27 |
Norton Healthcare Ltd |
A process for preparing a formulation
|
|
KR20220092565A
(ko)
|
2019-10-30 |
2022-07-01 |
씨아이에스 파르마 에이쥐 |
활성제를 전달하기 위한 생체 적합성 중합체 약물 담체
|
|
WO2021214279A1
(en)
|
2020-04-24 |
2021-10-28 |
Hsf Pharmaceuticals |
Replication-competent controlled herpesviruses expressing a sars cov-2 antigen
|
|
WO2021262799A1
(en)
|
2020-06-23 |
2021-12-30 |
Flagship Pioneering, Inc. |
Anti-viral compounds and methods of using same
|
|
ES2922973T1
(es)
|
2020-07-20 |
2022-09-22 |
Enanta Pharm Inc |
Peptidos funcionalizados como agentes antivirales
|
|
KR20230124582A
(ko)
|
2020-11-23 |
2023-08-25 |
이난타 파마슈티칼스, 인코포레이티드 |
신규한 스피로피롤리딘 유래 항바이러스제
|
|
WO2023006993A1
(en)
|
2021-07-30 |
2023-02-02 |
Atmosr |
Fused amino pyridine or pyrimidine derivatives for the treatment of congenital central hypoventilation syndrome
|
|
CN114177140A
(zh)
*
|
2021-12-10 |
2022-03-15 |
卓和药业集团股份有限公司 |
一种硫酸奈替米星气雾剂
|